Daniel Paul Ferrante DO
Obstetrics and Gynecology Department Chairman, High-Risk Pre-natal Clinic Medical Director, Medical Executive Committee Member at Saint Clare's Health, member of Prime Healthcare, Member of the Board Clinical Governance, Lifeline Medical Associates
Join to View Full Profile
16 Pocono ParkSuite 217Denville, NJ 07834
Phone+1 973-784-3935
Dr. Ferrante is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified obstetrician gynecologist with 33 years experience specializing in obstetrics, gynecology, gynecologic surgery and minimally invasive surgery. I am published in contraception research and most recently genetic screening protocols for Myriad Genetics. I continue to speak nationally on long term contraception, umbilical cord stem cell collection and genetic testing for gene mutations related to increased cancer risk. I am currently Chairman of the department of Obstetrics and Gynecology at Prime Healthcare, Saint Clare's health, N.J. and a member of the Board of Clinical Governance of Lifeline Medical associates. I am also a founding member of Lifeline Medical Associates, Unified Women's Health; now 155 single specialty providers, in New Jersey since 1997.
Education & Training
Christiana Care Health ServicesResidency, Obstetrics and Gynecology, 1987 - 1991
Rowan University School of Osteopathic MedicineClass of 1987
Certifications & Licensure
NJ State License 1989 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
Journal Articles
- Genetic cancer risk assessment by Women's Health Providers: Resource Solutions to Support Identification and Appropriate TestingDaniel Ferrante DO, Poster, 9/10/2024
- Compliance and insertion training Mirena levonorgestrel iud , United States multicenter trial.Daniel Ferrante DO principle investigator, Fertility, 1/17/1998
Committees
- Member as Chairman of Department of Obstetrics and Gynecology, Medical Executive Committee, Saint Clare's Health 2019 - Present
Research History
- Principle investigatorGenetic Cancer risk assessment by Women's Health Providers: Resources Solutions to Support Identification and Appropriate Testing2022 - 2023
- Principle InvestigatorMulticenter trial of new oral contraceptive.
- Principle InvestigatorA multicenter, Open-Label, Uncontrolled Trial with Levonorgestrel releasing Intrauterine System to evaluate the Insertion and Counseling Procedures Clinical Study Phase IIIB
Professional Memberships
- Fellow
Other Languages
- Italian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
